Expression, purification and characterization of the second Kunitz-type protease inhibitor domain of the human WFIKKN protein

21Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Recently we have described a novel secreted protein (the WFIKKN protein) that consists of multiple types of protease inhibitory modules, including two tandem Kunitz-type protease inhibitor-domains. On the basis of its homologies we have suggested that the WFIKKN protein is a multivalent protease inhibitor that may control the action of different proteases. In the present work we have expressed the second Kunitz-type protease inhibitor domain of the human protein WFIKKN in Escherichia coli, purified it by affinity chromatography on trypsin-Sepharose and its structure was characterized by CD spectroscopy. The recombinant protein was found to inhibit trypsin (Ki = 9.6 nM), but chymotrypsin, elastase, plasmin, pancreatic kallikrein, lung tryptase, plasma kallikrein, thrombin, urokinase or tissue plasminogen activator were not inhibited by the recombinant protein even at 1 μM concentration. In view of the marked trypsin-specificity of the inhibitor it is suggested that its physiological target may be trypsin.

Cite

CITATION STYLE

APA

Nagy, A., Trexler, M., & Patthy, L. (2003). Expression, purification and characterization of the second Kunitz-type protease inhibitor domain of the human WFIKKN protein. European Journal of Biochemistry, 270(9), 2101–2107. https://doi.org/10.1046/j.1432-1033.2003.03593.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free